Fennec Pharmaceuticals (FENC) Enterprise Value (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Enterprise Value of -$36.8 million for Q4 2025, down 67.62% on a QoQ basis from -$21.9 million in Q3 2025, and down 38.12% year-over-year from -$59.5 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Enterprise Value (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Enterprise Value history runs 16 years deep, the most recent figure standing at -$36.8 million for Q4 2025.
- Quarterly Enterprise Value fell 38.12% year-over-year to -$36.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$36.8 million (down 38.12% YoY) and the FY2025 annual result came in at -$36.8 million, down 38.12% from the prior year.
- Enterprise Value was -$36.8 million for Q4 2025 at Fennec Pharmaceuticals, down from -$21.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$12.4 million in Q3 2023 and bottomed at -$51.2 million in Q1 2024.
- A 5-year average of -$25.1 million and a median of -$23.2 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 58.33% — and 2024, when it tumbled 285.74%.
- Fennec Pharmaceuticals' Enterprise Value stood at -$21.1 million in 2021, then retreated by 12.67% to -$23.8 million in 2022, then soared by 44.19% to -$13.3 million in 2023, then plunged by 100.72% to -$26.6 million in 2024, then sank by 38.12% to -$36.8 million in 2025.
- Business Quant data shows FENC's Enterprise Value at -$36.8 million in Q4 2025, -$21.9 million in Q3 2025, and -$18.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | -36.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -36.79 Mn |
| Sep 30, 2025 | -21.95 Mn |
| Jun 30, 2025 | -18.71 Mn |
| Mar 31, 2025 | -22.68 Mn |
| Dec 31, 2024 | -26.63 Mn |
| Sep 30, 2024 | -40.32 Mn |
| Jun 30, 2024 | -43.05 Mn |
| Mar 31, 2024 | -51.18 Mn |
| Dec 31, 2023 | -13.27 Mn |
| Sep 30, 2023 | -12.40 Mn |
| Jun 30, 2023 | -14.96 Mn |
| Mar 31, 2023 | -13.27 Mn |
| Dec 31, 2022 | -23.77 Mn |
| Sep 30, 2022 | -29.75 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | -18.26 Mn |
| Dec 31, 2021 | -21.10 Mn |
| Sep 30, 2021 | -24.34 Mn |
| Jun 30, 2021 | -27.29 Mn |
| Mar 31, 2021 | -26.75 Mn |